Open Beta
TREN
MetriLume
TREN

US marketsBIAF

SEC-sourced researchBeta

BIAF

bioAffinity Technologies, Inc.

Company comparison ↗

Data passport

CIK
0001712762
Exchange
Nasdaq
Business activity
— · SIC 8731
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 9,362,022.0000 USD; December 2025: 6,161,959.0000 USD9.4M USD0 USD0December 2024December 2025
BIAF · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20249,362,022.0000Mar 16, 2026
December 20256,161,959.0000Mar 16, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20256,161,959.0000-14,909,754.0000-9,328,842.000010,960,772.00003,683,116.0000Mar 16, 2026
December 20249,362,022.0000-9,039,831.0000-7,264,795.00006,513,667.00003,911,631.0000Mar 16, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$6.16MDecember 2025Mar 16, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$9.36MDecember 2024Mar 16, 202610-K
Net incomeNetIncomeLoss-$14.91MDecember 2025Mar 16, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$9.33MDecember 2025Mar 16, 202610-K
Total assetsAssets$10.96MDecember 2025Mar 16, 202610-K
Total liabilitiesLiabilities$3.68MDecember 2025Mar 16, 202610-K

New filings

Explore methodology ↗